Intervention not reported
Adverse events · patients with antipsychotic‐induced TD
It is very uncertain whether the intervention changes adverse events (very low certainty).
1 finding from 1 review
Adverse events · antipsychotic‐related constipation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · antipsychotic‐related constipation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · antipsychotic‐related constipation
1 finding from 1 review
Adverse events · people with serious mental illness
1 finding from 1 review
Adverse events: any · patients with antipsychotic‐induced tardive dyskinesia
It is very uncertain whether benzodiazepines changes adverse events: any compared with phenobarbital (as active placebo) (very low certainty).
1 finding from 1 review
Adverse events: any · patients with schizophrenia
1 finding from 1 review
Adverse effects/events · patients with treatment compliance for people with serious mental illness
1 finding from 1 review
Adverse effects/events · Women at risk of postnatal psychosis
1 finding from 1 review
Adverse events: Lost to · patients with schizophrenia
It is very uncertain whether early warning signs training and treatment as usual changes adverse events: Lost to compared with treatment (very low certainty).
1 finding from 1 review
Adverse events: all cause · people with schizophrenia or other serious mental illness
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events: Any event · patients with people with schizophrenia who have neuroleptic‐induced weight or metabolic problems
The intervention showed no clear difference in adverse events: Any event (moderate certainty).
1 finding from 1 review
Adverse events: Not reported · Adolescents with psychosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events: Not reported · Adolescents with psychosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events: Not reported · Adolescents with psychosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not reported · patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Adverse events ‐ not reported · patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Adverse events ‐ not reported · patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Adverse events ‐ not reported · patients with antipsychotic‐induced tardive dyskinesia
1 finding from 1 review
Adverse events: General ‐ serious · patients with schizophrenia
RISPERIDONE DEPOT showed no clear difference in adverse events: General ‐ serious compared with ORAL OLANZAPINE (low certainty).
1 finding from 1 review